Cargando…

Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth

BACKGROUND: Preterm birth, defined as parturition before 37 completed weeks of gestation, is associated with an increased risk of neonatal complications and death, as well as poor health and disease later in life. Epigenetics could contribute to the mechanism underlying preterm birth. RESULTS: Genom...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Young-Ah, Kwon, Eun Jin, Hwang, Han-Sung, Choi, Suk-Joo, Choi, Sae Kyung, Kim, Young Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272312/
https://www.ncbi.nlm.nih.gov/pubmed/34246240
http://dx.doi.org/10.1186/s12864-021-07865-y
_version_ 1783721193081143296
author You, Young-Ah
Kwon, Eun Jin
Hwang, Han-Sung
Choi, Suk-Joo
Choi, Sae Kyung
Kim, Young Ju
author_facet You, Young-Ah
Kwon, Eun Jin
Hwang, Han-Sung
Choi, Suk-Joo
Choi, Sae Kyung
Kim, Young Ju
author_sort You, Young-Ah
collection PubMed
description BACKGROUND: Preterm birth, defined as parturition before 37 completed weeks of gestation, is associated with an increased risk of neonatal complications and death, as well as poor health and disease later in life. Epigenetics could contribute to the mechanism underlying preterm birth. RESULTS: Genome-wide DNA methylation analysis of whole blood cells from 10 women (5 term and 5 preterm deliveries) was performed using an Illumina Infinium HumanMethylation450 BeadChips array. We identified 1,581 differentially methylated CpG sites in promoter regions between term and preterm birth. Although the differences were not significant after correcting for multiple tests, seven CpGs on the genomically imprinted vault RNA2-1 (VTRNA2-1; also known as non-coding RNA, nc886 or miR-886) showed the largest differences (range: 26–39 %). Pyrosequencing verification was performed with blood samples from pregnant women recruited additionally (39 term and 43 preterm deliveries). In total, 28 (34.1 %) samples showed hypomethylation of the VTRNA2-1 promoter (< 13 % methylation), while 54 (65.9 %) samples showed elevated methylation levels between 30 and 60 %. Elevated methylation of VTRNA2-1 promoter was associated with an increased risk of preterm birth after adjusting for maternal age, season of delivery, parity and white blood cell count. The mRNA expression of VTRNA2-1 was 0.51-fold lower in women with preterm deliveries (n = 20) compared with women with term deliveries (n = 20). CONCLUSIONS: VTRNA2-1 is a noncoding transcript to environmentally responsive epialleles. Our results suggest that elevated methylation of the VTRNA2-1 promoter may result in increased risk of PTB caused by the pro-inflammatory cytokines. Further studies are needed to confirm the association of VTRNA2-1 methylation with preterm birth in a large population, and to elucidate the underlying mechanism. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07865-y.
format Online
Article
Text
id pubmed-8272312
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82723122021-07-12 Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth You, Young-Ah Kwon, Eun Jin Hwang, Han-Sung Choi, Suk-Joo Choi, Sae Kyung Kim, Young Ju BMC Genomics Research Article BACKGROUND: Preterm birth, defined as parturition before 37 completed weeks of gestation, is associated with an increased risk of neonatal complications and death, as well as poor health and disease later in life. Epigenetics could contribute to the mechanism underlying preterm birth. RESULTS: Genome-wide DNA methylation analysis of whole blood cells from 10 women (5 term and 5 preterm deliveries) was performed using an Illumina Infinium HumanMethylation450 BeadChips array. We identified 1,581 differentially methylated CpG sites in promoter regions between term and preterm birth. Although the differences were not significant after correcting for multiple tests, seven CpGs on the genomically imprinted vault RNA2-1 (VTRNA2-1; also known as non-coding RNA, nc886 or miR-886) showed the largest differences (range: 26–39 %). Pyrosequencing verification was performed with blood samples from pregnant women recruited additionally (39 term and 43 preterm deliveries). In total, 28 (34.1 %) samples showed hypomethylation of the VTRNA2-1 promoter (< 13 % methylation), while 54 (65.9 %) samples showed elevated methylation levels between 30 and 60 %. Elevated methylation of VTRNA2-1 promoter was associated with an increased risk of preterm birth after adjusting for maternal age, season of delivery, parity and white blood cell count. The mRNA expression of VTRNA2-1 was 0.51-fold lower in women with preterm deliveries (n = 20) compared with women with term deliveries (n = 20). CONCLUSIONS: VTRNA2-1 is a noncoding transcript to environmentally responsive epialleles. Our results suggest that elevated methylation of the VTRNA2-1 promoter may result in increased risk of PTB caused by the pro-inflammatory cytokines. Further studies are needed to confirm the association of VTRNA2-1 methylation with preterm birth in a large population, and to elucidate the underlying mechanism. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07865-y. BioMed Central 2021-07-10 /pmc/articles/PMC8272312/ /pubmed/34246240 http://dx.doi.org/10.1186/s12864-021-07865-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
You, Young-Ah
Kwon, Eun Jin
Hwang, Han-Sung
Choi, Suk-Joo
Choi, Sae Kyung
Kim, Young Ju
Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth
title Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth
title_full Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth
title_fullStr Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth
title_full_unstemmed Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth
title_short Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth
title_sort elevated methylation of the vault rna2-1 promoter in maternal blood is associated with preterm birth
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272312/
https://www.ncbi.nlm.nih.gov/pubmed/34246240
http://dx.doi.org/10.1186/s12864-021-07865-y
work_keys_str_mv AT youyoungah elevatedmethylationofthevaultrna21promoterinmaternalbloodisassociatedwithpretermbirth
AT kwoneunjin elevatedmethylationofthevaultrna21promoterinmaternalbloodisassociatedwithpretermbirth
AT hwanghansung elevatedmethylationofthevaultrna21promoterinmaternalbloodisassociatedwithpretermbirth
AT choisukjoo elevatedmethylationofthevaultrna21promoterinmaternalbloodisassociatedwithpretermbirth
AT choisaekyung elevatedmethylationofthevaultrna21promoterinmaternalbloodisassociatedwithpretermbirth
AT kimyoungju elevatedmethylationofthevaultrna21promoterinmaternalbloodisassociatedwithpretermbirth